scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1101017636 |
P356 | DOI | 10.1007/S11883-018-0715-0 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s11883-018-0715-0 |
P698 | PubMed publication ID | 29445885 |
P50 | author | Alberico L. Catapano | Q37841297 |
Angela Pirillo | Q38600937 | ||
P2093 | author name string | Giuseppe Danilo Norata | |
Fabrizia Bonacina | |||
P2860 | cites work | The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta | Q24305136 |
Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 | ||
Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease | Q24649709 | ||
Long-term activation of the innate immune system in atherosclerosis | Q26750473 | ||
Transcriptional regulation of hepatic lipogenesis | Q26778594 | ||
Dendritic cells in atherosclerosis: evidence in mice and humans | Q28083158 | ||
Cholesterol, inflammation and innate immunity | Q28086912 | ||
Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice | Q57967556 | ||
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus | Q60241027 | ||
Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice | Q62735862 | ||
The Inflammasome in Atherosclerosis and Type 2 Diabetes | Q62818661 | ||
Lipoprotein receptors and the genetic control of cholesterol metabolism in cultured human cells | Q66843848 | ||
Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes | Q88027071 | ||
Infections, atherosclerosis, and coronary heart disease | Q89605356 | ||
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation | Q28506984 | ||
Lactate Regulates Metabolic and Pro-inflammatory Circuits in Control of T Cell Migration and Effector Functions | Q28546616 | ||
IL-18 overexpression promotes vascular inflammation and remodeling in a rat model of metabolic syndrome | Q28574307 | ||
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice | Q28591350 | ||
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data | Q28742740 | ||
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins | Q29547856 | ||
Thioredoxin-interacting protein links oxidative stress to inflammasome activation | Q29614471 | ||
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals | Q29615704 | ||
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling | Q29616024 | ||
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials | Q29617910 | ||
Interleukin 18 binding protein (IL18-BP) inhibits neointimal hyperplasia after balloon injury in an atherosclerotic rabbit model | Q33331640 | ||
Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. | Q34188006 | ||
Emerging role of high density lipoproteins as a player in the immune system. | Q34202968 | ||
Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. | Q34377352 | ||
Infusion of pharmaceutical-grade natural human C-reactive protein is not proinflammatory in healthy adult human volunteers | Q34391885 | ||
Inflammation, metaflammation and immunometabolic disorders | Q34550852 | ||
Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis | Q34629713 | ||
Genetically elevated C-reactive protein and ischemic vascular disease | Q34868720 | ||
Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome | Q35006409 | ||
Effects of an antisense oligonucleotide inhibitor of C-reactive protein synthesis on the endotoxin challenge response in healthy human male volunteers | Q35026389 | ||
Membrane microdomains and vascular biology: emerging role in atherogenesis | Q35122046 | ||
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice | Q35160907 | ||
ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice | Q35370268 | ||
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials | Q35645239 | ||
LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling | Q35896184 | ||
Cardiovascular disease and rheumatoid arthritis: an update | Q36218375 | ||
Role of cholesterol and lipid organization in disease | Q36327808 | ||
Linking innate to adaptive immunity through dendritic cells. | Q36728264 | ||
Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity | Q36839721 | ||
Lipid droplet-associated proteins in atherosclerosis (Review). | Q36931267 | ||
LXR signaling couples sterol metabolism to proliferation in the acquired immune response. | Q37061238 | ||
Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia | Q37276351 | ||
Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis | Q37466366 | ||
Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release | Q37700323 | ||
Obesity-Induced Metabolic Stress Leads to Biased Effector Memory CD4+ T Cell Differentiation via PI3K p110δ-Akt-Mediated Signals. | Q37707116 | ||
Revitalizing membrane rafts: new tools and insights | Q37791416 | ||
Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls | Q37810960 | ||
HDLs, immunity, and atherosclerosis. | Q37924543 | ||
Lipid rafts: a signalling platform linking lipoprotein metabolism to atherogenesis | Q37954496 | ||
Inflammation and atherosclerosis: direct versus indirect mechanisms | Q38077322 | ||
HDL in innate and adaptive immunity. | Q38220759 | ||
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial | Q38384675 | ||
Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans | Q38389141 | ||
The Cellular and Molecular Basis of Translational Immunometabolism. | Q38588211 | ||
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial | Q38601785 | ||
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease | Q38606033 | ||
Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque | Q38679802 | ||
Trained immunity: A program of innate immune memory in health and disease. | Q38814347 | ||
Lipid rafts in immune signalling: current progress and future perspective. | Q38827777 | ||
Foamy monocytes form early and contribute to nascent atherosclerosis in mice with hypercholesterolemia | Q38860053 | ||
A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy | Q38936733 | ||
Pleiotropic Effects of Statins on the Cardiovascular System | Q39069187 | ||
Vascular inflammation and low-density lipoproteins: is cholesterol the link? A lesson from the clinical trials | Q39215606 | ||
Metabolic Instruction of Immunity. | Q39286043 | ||
Frequency of Cholesterol Crystals in Culprit Coronary Artery Aspirate During Acute Myocardial Infarction and Their Relation to Inflammation and Myocardial Injury. | Q40059965 | ||
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease | Q40287836 | ||
Location of major histocompatibility complex class II molecules in rafts on dendritic cells enhances the efficiency of T-cell activation and proliferation | Q40332851 | ||
Postprandial Monocyte Activation in Individuals With Metabolic Syndrome. | Q40467008 | ||
Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice | Q40506477 | ||
Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation | Q40820913 | ||
Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development in Ldlr(-/-) mice | Q41147790 | ||
SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid Metabolism | Q41501239 | ||
The role of dendritic cells in T cell activation. | Q41550864 | ||
Role of NLRP3 Inflammasomes in Atherosclerosis | Q41787404 | ||
ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation | Q41789790 | ||
Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. | Q41862465 | ||
CD11c/CD18 Signals Very Late Antigen-4 Activation To Initiate Foamy Monocyte Recruitment during the Onset of Hypercholesterolemia | Q42629748 | ||
Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. | Q42729920 | ||
Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessment | Q43228817 | ||
Cholesterol Accumulation in CD11c+ Immune Cells Is a Causal and Targetable Factor in Autoimmune Disease | Q44921258 | ||
Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis | Q46323475 | ||
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial | Q47394886 | ||
Monocyte-Macrophages and T Cells in Atherosclerosis | Q47632654 | ||
Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis | Q47993155 | ||
HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells. | Q52628286 | ||
Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity. | Q52772414 | ||
Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus | Q56899717 | ||
Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease | Q57243317 | ||
P433 | issue | 3 | |
P921 | main subject | atherosclerosis | Q12252367 |
P304 | page(s) | 12 | |
P577 | publication date | 2018-02-14 | |
P1433 | published in | Current Atherosclerosis Reports | Q20821076 |
P1476 | title | The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis | |
P478 | volume | 20 |
Q92404808 | Circular RNA circ_0003204 inhibits proliferation, migration and tube formation of endothelial cell in atherosclerosis via miR-370-3p/TGFβR2/phosph-SMAD3 axis |
Q98735442 | Dendritic Cells and T Cells, Partners in Atherogenesis and the Translating Road Ahead |
Q90782102 | Early life feeding and current dietary patterns are associated with biomarkers of glucose and lipid metabolism in young women from the Nutritionist's Health Study |
Q90015714 | Emerging techniques in atherosclerosis imaging |
Q91925347 | HDL-C to hsCRP ratio is associated with left ventricular diastolic function in absence of significant coronary atherosclerosis |
Q58788879 | Long noncoding RNA TCONS_00024652 regulates vascular endothelial cell proliferation and angiogenesis via microRNA-21 |
Q90737580 | Methotrexate Decreases the Level of PCSK9-A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data |
Q58706139 | Morning hypertension is a risk factor of macrovascular events following cerebral infarction: A retrospective study |
Q97536508 | NLRP3 inflammasome via IL-1β regulates PCSK9 secretion |
Q58701054 | Regulatory effect of Phikud Navakot extract on HMG-CoA reductase and LDL-R: potential and alternate agents for lowering blood cholesterol |
Search more.